Anthony Evnin
Director
R & D
Infinity Pharmaceuticals
United States of America
Biography
Anthony Evnin, Ph.D., lead outside director for Infinity and chair of Infinity’s Nominating and Governance Committee, has been a Partner of Venrock, a venture capital firm, since 1975. Dr. Evnin currently serves on the Board of Directors of AVEO Pharmaceuticals and Juno Therapeutics as well as on the Board of one private company, Constellation Pharmaceuticals. He is a Member of the Boards of Overseers and Managers of Memorial Sloan-Kettering Cancer Center, a Trustee of The Rockefeller University, a Trustee of The Jackson Laboratory, a Director of the New York Genome Center, a Member of the Board of Directors of the Albert and Mary Lasker Foundation, and a Trustee Emeritus of Princeton University. Dr. Evnin received an A.B. in chemistry from Princeton University and a Ph.D. in chemistry from the Massachusetts Institute of Technology.
Research Interest
Pharmaceuticals and Juno Therapeutics as well as on the Board of one private company, Constellation Pharmaceuticals
